Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-24 @ 11:56 PM
NCT ID:
NCT04840251
Eligibility Criteria:
Inclusion Criteria:
* in World Health Organisation (WHO) Functional Class II or III
* have a diagnosis of PH
* have started on PH drug therapy in the preceding 18 months
* showing no signs of worsening breathlessness or heart failure
* on an unchanged PH therapeutic regime for at least 6 months prior to inclusion.
Exclusion Criteria:
* have an active infection or acute exacerbation of lung disease
* have participated in a clinical study involving another investigation of drug, device or exercise within the previous 6 months
* are on a surgical or other pathway of care that has pre-determined physiotherapy or activity regimes or restrictions
* have any additional medical conditions that may adversely affect the safety of the subject or severely limit the lifespan of the subject
* have participated in rehabilitation in the last 12 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04840251
Study Brief:
Protocol Section:
NCT04840251